• Aug. 01, 2019Finances

  Posted Conference Call for Q1 FY2019 [Webcast]

• Jul. 31, 2019 (PDF/123KB)R&D

  Sumitomo Dainippon Pharma Submits New Drug Application for Approval of Manufacturing and Marketing for Lurasidone in Japan for the Treatment of Schizophrenia and Bipolar Depression

• Jul. 31, 2019 (PDF/173KB)R&D

  Sunovion Announces Acceptance by the U.S. FDA of the New Drug Application for Dasotraline for the Treatment of Adults with Moderate-to-Severe Binge Eating Disorder

• Jul. 29, 2019 (PDF/582KB)Finances

  Presentation Material (First Quarter Financial Results for FY2019)

• Jul. 29, 2019 (PDF/457KB)Finances

  Supplementary Financial Data (IFRS) for the First Quarter of the Year Ending March 31, 2020

more